ACE2 and chronic obstructive pulmonary disease: We therefore cannot currently ascertain whether the clear suppressive effect of ICS on ACE2 expression that was shown in our experiments would result in ICS use in COPD having overall protective or detrimental effects in the context of clinical disease.